Ellagic acid inhibits human colon cancer HCT-116 cells by regulating long noncoding RNAs.
Anticancer Drugs
; 34(10): 1112-1121, 2023 Nov 01.
Article
in En
| MEDLINE
| ID: mdl-36847079
ABSTRACT
The natural phenolic compound ellagic acid exerts anti-cancer effects, including activity against colorectal cancer (CRC). Previously, we reported that ellagic acid can inhibit the proliferation of CRC, and can induce cell cycle arrest and apoptosis. This study investigated ellagic acid-mediated anticancer effects using the human colon cancer HCT-116 cell line. After 72 h of ellagic acid treatment, a total of 206 long noncoding RNAs (lncRNAs) with differential expression greater than 1.5-fold were identified (115 down-regulated and 91 up-regulated). Furthermore, the co-expression network analysis of differentially expressed lncRNA and mRNA showed that differential expressed lncRNA might be the target of ellagic acid activity in inhibiting CRC.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Anticancer Drugs
Journal subject:
ANTINEOPLASICOS
Year:
2023
Document type:
Article